Aptose Biosciences Return on Net Operating Assets Analysis

Aptose Biosciences, Inc. (APTOF)

1.630 0.00 (0.00%) USD | OTCM | Feb 19, 16:00

View Return on Net Operating Assets for APTOF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Oncolytics Biotech, Inc.	Upgrade
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Lexaria Bioscience Corp.	Upgrade
Xenon Pharmaceuticals, Inc.	Upgrade

Return on Assets	Upgrade
Return on Invested Capital	Upgrade